MedinCell S.A. (EPA:MEDCL)
22.86
-0.94 (-3.95%)
Apr 28, 2026, 5:35 PM CET
MedinCell Employees
MedinCell had 145 employees as of September 30, 2025. The number of employees increased by 14 or 10.69% since the number was reported on March 31, 2025.
Employees
145
Change
14
Growth
10.69%
Revenue / Employee
€223,717
Profits / Employee
€137,572
Market Cap
820.77M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Inventiva | 77 |
| DBV Technologies | 117 |
| Nanobiotix | 103 |
| Valneva SE | 674 |
| Genfit | 188 |
| Cellectis | 229 |
| Transgene | 145 |
| Sensorion | 63 |
MedinCell News
- 12 days ago - Medincell to Host an Online R&D Day on Tuesday, May 12, 2026 - Business Wire
- 2 months ago - Medincell to Present at the TD Cowen 46th Annual Healthcare Conference in Boston, March 2-4, 2026 - Business Wire
- 2 months ago - FDA Accepts NDA For Teva And Medincell's Olanzapine LAI In Schizophrenia Treatment - Nasdaq
- 3 months ago - Medincell - UZEDY®: Net Sales Increased from $117M in 2024 to $191M in 2025 (+63%) - Business Wire
- 5 months ago - MedinCell Transcript: H1 25/26 - Transcripts
- 5 months ago - MedinCell Transcript: Evercore ISI 8th Annual HealthCONx Conference - Transcripts
- 5 months ago - MedinCell Transcript: Jefferies London Healthcare Conference 2025 - Transcripts
- 7 months ago - Teva : FDA Grants Expanded Approval For UZEDY To Treat Bipolar I Disorder In Adults - Nasdaq